Back to results
US 12,390,481 B2Granted
Sialic acid compositions for the use of inhibiting and treating coronavirus infection
AssigneeLifeScience AS
InventorJan Remmereit
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of compositions comprising sialic acid to inhibit or treat coronavirus infections, and in particular those caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
Claims6
A method for inhibiting infection by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), in a human subject at risk of infection by SARS-CoV-2, the method comprising:
- contacting nasal mucosa of the subject with a formulation comprising n-acetylneuraminic acid (NANA) in an effective concentration to the subject under conditions such that infection by SARS-CoV-2 is inhibited, wherein the formulation is delivered as a spray, gel, or solution comprising said NANA.
Dependencies are inferred from the claim text.